These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 21615150)

  • 1. Progress in structure based drug design for G protein-coupled receptors.
    Congreve M; Langmead CJ; Mason JS; Marshall FH
    J Med Chem; 2011 Jul; 54(13):4283-311. PubMed ID: 21615150
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric drugs and seven transmembrane receptors.
    Kenakin T
    Curr Top Med Chem; 2013; 13(1):5-13. PubMed ID: 23409762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
    Congreve M; Oswald C; Marshall FH
    Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein-coupled receptors in drug discovery--seventh annual Informa conference. Part 1--GPCR structures and ligand binding.
    Jockers R
    IDrugs; 2009 May; 12(5):285-8. PubMed ID: 19431090
    [No Abstract]   [Full Text] [Related]  

  • 5. Allosteric modulation as a unifying mechanism for receptor function and regulation.
    Changeux JP; Christopoulos A
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():4-21. PubMed ID: 28880476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.
    Hino T; Arakawa T; Iwanari H; Yurugi-Kobayashi T; Ikeda-Suno C; Nakada-Nakura Y; Kusano-Arai O; Weyand S; Shimamura T; Nomura N; Cameron AD; Kobayashi T; Hamakubo T; Iwata S; Murata T
    Nature; 2012 Jan; 482(7384):237-40. PubMed ID: 22286059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.
    Soudijn W; Van Wijngaarden I; IJzerman AP
    Drug Discov Today; 2004 Sep; 9(17):752-8. PubMed ID: 15450241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation.
    Changeux JP; Christopoulos A
    Cell; 2016 Aug; 166(5):1084-1102. PubMed ID: 27565340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.
    Dror RO; Green HF; Valant C; Borhani DW; Valcourt JR; Pan AC; Arlow DH; Canals M; Lane JR; Rahmani R; Baell JB; Sexton PM; Christopoulos A; Shaw DE
    Nature; 2013 Nov; 503(7475):295-9. PubMed ID: 24121438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.
    Chaturvedi M; Schilling J; Beautrait A; Bouvier M; Benovic JL; Shukla AK
    Trends Biochem Sci; 2018 Jul; 43(7):533-546. PubMed ID: 29735399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding and micro-switches in 7TM receptor structures.
    Nygaard R; Frimurer TM; Holst B; Rosenkilde MM; Schwartz TW
    Trends Pharmacol Sci; 2009 May; 30(5):249-59. PubMed ID: 19375807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
    Ortiz Zacarías NV; Lenselink EB; IJzerman AP; Handel TM; Heitman LH
    Trends Pharmacol Sci; 2018 Jun; 39(6):547-559. PubMed ID: 29653834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors.
    Valant C; Robert Lane J; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2012; 52():153-78. PubMed ID: 21910627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of tractable allosteric sites in G protein-coupled receptors.
    Wakefield AE; Mason JS; Vajda S; Keserű GM
    Sci Rep; 2019 Apr; 9(1):6180. PubMed ID: 30992500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of kinases and GPCRs: design principles and structural diversity.
    Lewis JA; Lebois EP; Lindsley CW
    Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into G-protein-coupled receptor allostery.
    Thal DM; Glukhova A; Sexton PM; Christopoulos A
    Nature; 2018 Jul; 559(7712):45-53. PubMed ID: 29973731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.
    Jazayeri A; Dias JM; Marshall FH
    J Biol Chem; 2015 Aug; 290(32):19489-95. PubMed ID: 26100628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.